Breast Cancer Advice. Keep up to date with the latest information and treatment of breast cancer.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Protein Test Spots Risk for Breast, Ovarian Cancer

FANCD2 illuminates a new kind of genetic danger, experts explain

FRIDAY, Sept. 15 (HealthDay News) -- A key protein may help doctors spot women at hidden risk for developing breast and ovarian cancer, according to new research.

Some women do not have mutations in the BRCA1 or BRCA2 genes for breast and ovarian cancer but still have a strong family history of these cancers.

Related Stories
Black Women's Genes May Spur Deadlier Breast Cancer
Breast Cancer Drugs Not One-Size-Fits-All
Digital Mammography Boosts Chances of Spotting Malignancies
Related Videos
Attacking Advanced Breast Cancer
Keep Ovarian Cancer At Bay
Easing Radiation Side Effects
Related Slides
Breast Cancer
Breast Self-Exam

"We knew that there must have been something else that we could track genetically," principal investigator Tanja Pejovic, an associate professor of obstetrics and gynecology at the Oregon Health & Science University School of Medicine, said in a prepared statement.

In a study appearing in the Sept. 15 issue of Cancer Research, researchers from the Oregon Health & Science University Cancer Institute examined the ovarian tissue of 22 women.

That found that those who had a family history of ovarian cancer but no BRCA mutations had a low level of a protein known as FANCD2, which normally protects DNA and helps repair broken chromosomes. In women with low levels of FANCD2, cells from the ovary were unable to be repaired, putting them at risk of developing cancer-causing mutations.

"Basically we have discovered that by testing ovarian cells for chromosome breakage, we may be able to identify many more women at risk for ovarian and breast cancer than by using BRCA1 and BRCA2 mutation testing," said Pejovic.

She believes these findings may lead a cancer screening method that uses minimally invasive surgery to remove a few epithelial cells from the ovary for testing. During tests, doctors would look for signs of chromosomal breakage.

"Once this method is fully developed," she said, "we will be able to tell a young woman who has a family history of ovarian or breast cancer, but who wants to have children, whether she is at risk or not, without removing her ovary."

More information

The National Cancer Institute has more about breast cancer ( ).

Krisha McCoy

SOURCE: Oregon Health & Science University, news release, Sept. 15, 2006

Copyright © 2006 ScoutNews LLC. All rights reserved.
Last updated 9/15/2006

Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.

Nov 14, 2006
New! For timely and trustworth health information, expert advice and much more, visit Breast Cancer Connection
Patient Guide
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Privacy Policy
Terms of Use

We subscribe to the HONcode principles of the Health On the Net Foundation
About The HealthScout Network Contact Us
Copyright 2001-2006 Choicemedia, Inc. All rights reserved.

Please visit our partner sites: